迈科康生物 迈科康生物

CN

Adjuvant technology platform

HIT:1225

Our adjuvant technology platform has nearly 20 kinds of adjuvant raw materials, achieved independent design and production, controlled the cost and quality, and got rid of the dependence on raw materials import, and has reached the forefront of the world in terms of quantity. Based on the innovative adjuvant formula, production process and advanced quality management concept, three types of mature transmission systems have been built, and more than 10 kinds of new adjuvant systems have been developed, including optimized aluminum adjuvant, nanoemulsion adjuvant, composite adjuvant, etc. Based on the protection mechanism of the candidate vaccine, it can match the appropriate adjuvant system, assist in antigen presentation, enhance the immune response and regulate the type of immune response.